Services available to members
- Support for investigator-initiated trials in cancer
- Pathology Support Laboratory at The Children's Hospital at Westmead
- Sydney Bioinformatics
- Sydnovate, University of Sydney
A partnership between the NHMRC Clinical Trials Centre (CTC) and the Cancer Institute NSW has been established to encourage the development of investigator-initiated cancer clinical trials by providing operational and statistical support.
The partnership aims to establish and develop new cancer trials and collaborations in areas which are currently underrepresented by clinical research. The partnership will be used to build on existing expertise, strengths and resources to provide strong links with existing groups and partners.
What can the partnership do for you?
Applicants may request statistical support, operational support or both. The support available includes:
- statistical support for an early proposal (e.g. sample size, analysis plans);
- statistical review of a protocol leading to a report with recommendations;
- trial development including concept outlines, feasibility surveys, protocols, case report forms;
- operational support to plan conduct of the clinical trial (including initiation, coordination, data management, statistical support, monitoring); and
- operational support in part (e.g. randomisation).
The partnership provides an opportunity for investigators to develop clinical trial initiatives and will work in collaboration to seek funds for the conduct of the main study. Full trial funding is not available through the partnership.
For useful documents and further information, including who can access the partnership, please visit the NHMRC Clinical Trials Centre website.
Vital to the use of human tissue in research applications is the availability of specialised research-oriented histopathology services. The availability of such specialised histopathology services is currently limited with cancer researchers often relying on collaborative relationships and goodwill with hospital pathologists, whose time is often limited.
A Pathology Support Laboratory (PSL) has been established within The Children’s Hospital at Westmead Tumour Bank to facilitate research through the provision of research-based tissue handling techniques which may be of interest to University of Sydney cancer researchers using biospecimens as part of their research. PSL services include:
- The provision of basic tissue sectioning and standard stains, as well as high through-put immunohistochemistry for known or novel targets;
- The creation of tissue microarrays; and
- The provision of a digital platform for scanning microscope slides which generates high resolution images of tissue sections that can viewed at remote sites via the internet, facilitating pathology review by experts around the world and access to ‘virtual’ microscopy facilities.
For further details, please contact:
The Tumour Bank
The Oncology Research Unit
The Children’s Hospital at Westmead
Locked Bag 4001
Westmead NSW 2145
Phone 02 98451205 or 02 98453028
Bioinformatics is the application of information technologies and sciences to the organisation, management, mining and use of life-science information. Sydney Bioinformatics provides a core facility for cancer researchers at the University of Sydney, its affiliated research institutes and teaching hospitals.
Sydney Bioinformatics offers a suite of professional bioinformatics services including: collaborative research, expert assistance, advice, consultancy as well as customised data analysis and software development. Vocational and educational training in the use of bioinformatics is a key service provided to postgraduate students, research staff and academic staff. Sydney Bioinformatics is home to the Australian National Genomic Information Service (ANGIS) and can provide access to online bioinformatics software for cancer research.
To find out more visit the Sydney Bioinformatics website or contact Dr Jonathan Arthur (Director) by or by phone (02) 9036 3132.
Sydnovate is the commercial arm of The University of Sydney.
The main mission of Sydnovate is to ensure that technologies and innovations from the University of Sydney will develop into successful products. As a publicly funded institution, the University sees this as one of the ways in which it can serve the people that support its activities. Sydnovate is responsible for the identification, protection and licensing of Intellectual Property developed at the University.
Sydnovate holds a large portfolio of novel and exciting technologies that cover the entire spectrum of modern science, including cancer. Sydnovate invites industrial partners and entrepreneurs to team up with them in turning these technologies into useful and successful products.